Literature DB >> 16618265

The impact of migraine on patients with major depressive disorder.

Ching-I Hung1, Chia-Yih Liu, Yeong-Yuh Juang, Shuu-Jiun Wang.   

Abstract

BACKGROUND: The impact of migraine and other headache types among psychiatric outpatients with major depressive disorder (MDD) has not been fully described.
OBJECTIVE: To investigate the impact of migraine on the severity, physical, and anxiety symptoms in patients with MDD and to examine the interaction between headache and depression.
METHODS: This clinic-based study enrolled consecutive psychiatric outpatients meeting DSM-IV criteria for MDD. Headache types were diagnosed based on the International Classification of Headache Disorders, 2nd edition (2004). Three psychometric instruments were used to evaluate anxiety, depression, and physical components: the Hamilton Depression Rating Scale, the Beck Depression Inventory, and the Hospital Anxiety and Depression Scale. In addition, the interactions between headache and their depressive episode were also evaluated.
RESULTS: Compared with patients without migraine, MDD patients with comorbid migraine (n = 73, 48.3%) had higher physical and anxiety scores on the three psychometric instruments. Migraine accounted for 5% to 11% of the variance of the total scores on the three psychometric scales. Approximately half (48.5%) of patients reported headache worsening during or after a depressive episode.
CONCLUSIONS: Our study found that comorbidity of migraine in patients with MDD was associated with more anxiety and physical symptoms. Headache should not be considered as only a somatic symptom of depression, but should be treated as an important comorbid disorder because it might exacerbate or interact with depression during a depressive episode.

Entities:  

Mesh:

Year:  2006        PMID: 16618265     DOI: 10.1111/j.1526-4610.2006.00378.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  9 in total

1.  Migraine genetics: current findings and future lines of research.

Authors:  A M Persico; M Verdecchia; V Pinzone; V Guidetti
Journal:  Neurogenetics       Date:  2014-12-14       Impact factor: 2.660

Review 2.  Migraine-associated risks and comorbidity.

Authors:  H C Diener; M Küper; T Kurth
Journal:  J Neurol       Date:  2008-09-30       Impact factor: 4.849

3.  Nociceptive and anxiety-like behavior in reproductively competent and reproductively senescent middle-aged rats.

Authors:  Alicia A Walf; Jason J Paris; Cheryl A Frye
Journal:  Gend Med       Date:  2009

4.  Headache, anxiety and depressive disorders: the HADAS study.

Authors:  Ettore Beghi; Gennaro Bussone; Domenico D'Amico; Pietro Cortelli; Sabina Cevoli; Gian Camillo Manzoni; Paola Torelli; Maria Clara Tonini; Giovanni Allais; Roberto De Simone; Florindo D'Onofrio; Sergio Genco; Franca Moschiano; Massimiliano Beghi; Sara Salvi
Journal:  J Headache Pain       Date:  2010-01-27       Impact factor: 7.277

5.  Depression, poor sleep, and sexual dysfunction in migraineurs women.

Authors:  Mahsa Ghajarzadeh; Rozita Jalilian; Mansoureh Togha; Amirreza Azimi; Pegah Hosseini; Nazanin Babaei
Journal:  Int J Prev Med       Date:  2014-09

6.  Overlap between Headache, Depression, and Anxiety in General Neurological Clinics: A Cross-sectional Study.

Authors:  Cui-Bai Wei; Jian-Ping Jia; Fen Wang; Ai-Hong Zhou; Xiu-Mei Zuo; Chang-Biao Chu
Journal:  Chin Med J (Engl)       Date:  2016-06-20       Impact factor: 2.628

7.  Levels of circulating endothelial progenitor cells inversely correlate with manic and positive symptom severity in patients with bipolar disorder.

Authors:  Ying-Jay Liou; Mu-Hong Chen; Ju-Wei Hsu; Kai-Lin Huang; Po-Hsun Huang; Ya-Mei Bai
Journal:  Brain Behav       Date:  2022-04-28       Impact factor: 3.405

8.  Migraine predicts physical and pain symptoms among psychiatric outpatients.

Authors:  Ching-I Hung; Chia-Yih Liu; Shuu-Jiun Wang
Journal:  J Headache Pain       Date:  2013-02-27       Impact factor: 7.277

9.  Associations between increased circulating endothelial progenitor cell levels and anxiety/depressive severity, cognitive deficit and function disability among patients with major depressive disorder.

Authors:  Ying-Jay Liou; Mu-Hong Chen; Ju-Wei Hsu; Kai-Lin Huang; Po-Hsun Huang; Ya-Mei Bai
Journal:  Sci Rep       Date:  2021-09-14       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.